leukaemia

AstraZeneca: two trials show long-term efficacy and tolerability of Calquence (acalabrutinib) in chronic lymphocytic leukaemia

ACE-CL-001 trial showed an overall response rate of 97% with a sustained safety profile for previously untreated patients after more…

4 years ago

AstraZeneca, Acerta Pharma, MedImmune to present at the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego

27 scientific presentations, including long-term data from Calquence in mantle cell lymphoma and updated early-phase trial results in chronic lymphocytic…

5 years ago

2013 Teenage Cancer Trust line up announced, report LondonTown.com

Noel Gallagher’s handpicked musical line up promises to thrill at Royal Albert Hall charity gigs 12-3-2013 — /europawire.eu/ — This March…

11 years ago